Prolactin is involved in the systemic inflammatory response in myocardial infarction

Hormone and Metabolic Research

Volumn 43, Issue 1, 2011, Pages 62-65

  Reuwer, A Q ^a   Van Zaane, B ^a,b   Van Wissen, M ^b   Van Zanten, A P ^b   Twickler, M T B ^a   Gerdes, V E A ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

inflammation; myocardial infarction; prolactin

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE MB; PROLACTIN; TROPONIN;

ACUTE STRESS; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROLACTIN;

EID: 78650942222     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1265221     Document Type: Article

References (19)

1. van Zaane B, Reuwer AQ, Buller HR, Kastelein JJ, Gerdes VE, Twickler MT. Hormones and cardiovascular disease: a shift in paradigm with clinical consequences? Semin Thromb Hemost 2009 35 478-487
2. Horseman ND. Prolactin and mammary gland development. J Mammary Gland Biol Neoplasia 1999 4 79-88
3. Erem C, Kocak M, Nuhoglu I, Yilmaz M, Ucuncu O. Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma. Clin Endocrinol (Oxf) 2009 December 18 [Epub ahead of print]
4. Pelkonen R, Nikkila EA, Grahne B. Serum lipids, postheparin plasma lipase activities and glucose tolerance in patients with prolactinoma. Clin Endocrinol (Oxf) 1982 16 383-390
5. Serri O, Li L, Mamputu JC, Beauchamp MC, Maingrette F, Renier G. The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clin Endocrinol (Oxf) 2006 64 366-370
6. Yavuz D, Deyneli O, Akpinar I, Yildiz E, Gözü H, Sezgin O, Haklar G, Akalin S. Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women. Eur J Endocrinol 2003 149 187-193
7. Georgiopoulos GA, Stamatelopoulos KS, Lambrinoudaki I, Lykka M, Kyrkou K, Rizos D, Creatsa M, Christodoulakos G, Alevizaki M, Sfikakis PP, Papamichael C. Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors. Hypertension 2009 54 98-105
8. Raaz D, Wallaschofski H, Stumpf C, Yilmaz A, Cicha I, Klinghammer L, Daniel WG, Lohmann T, Garlichs CD. Increased prolactin in acute coronary syndromes as putative Co-activator of ADP-stimulated P-selectin expression. Horm Metab Res 2006 38 767-772
9. Gordon EM, Hellerstein HK, Ratnoff OD, Arafah BM, Yamashita TS. Augmented Hageman factor and prolactin titers, enhanced cold activation of factor VII, and spontaneous shortening of prothrombin time in survivors of myocardial infarction. J Lab Clin Med 1987 109 409-413
10. La Follette L, Gordon EM, Mazur CA, Ratnoff OD, Yamashita TS. Hyperprolactinemia and reduction in plasma titers of Hageman factor, prekallikrein, and high molecular weight kininogen in patients with acute myocardial infarction. J Lab Clin Med 198 110 318-321
11. Webster Marketon JI, Glaser R. Stress hormones and immune function. Cell Immunol 2008 252 16-26
12. Ferrari R, Ceconi C, Rodella A, Harris P, Visioli O. Hormonal response in untreated myocardial infarction. Cardioscience 1990 1 55-60
13. Horrobin DF, McNeilly AS, Jackson FS, Reid DS, Tynan M, Nassar BA, Manku MS, Elliott K. Letter: Prolactin and myocardial infarction. Lancet 1973 2 1261
14. Weizman R, Eldar M, Hod H, Eshkol A, Rabinowitz B, Tyano S, Neufeld HN. Effects of uncomplicated acute myocardial infarction on biochemical parameters of stress and sexual function. Psychosomatics 1991 32 275-279
15. Chikanza IC, Grossman AB. Neuroendocrine immune responses to inflammation: the concept of the neuroendocrine immune loop. Baillieres Clin Rheumatol 1996 10 199-225
16. Kelley KW, Weigent DA, Kooijman R. Protein hormones and immunity. Brain Behav Immun 2007 21 384-392
17. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, Flaherty JT, Harrington RA, Krumholz HM, Simoons ML, Van De Werf FJ, Weintraub WS, Mitchell KR, Morrisson SL, Brindis RG, Anderson HV, Cannom DS, Chitwood WR, Cigarroa JE, Collins-Nakai RL, Ellis SG, Gibbons RJ, Grover FL, Heidenreich PA, Khandheria BK, Knoebel SB, Krumholz HL, Malenka DJ, Mark DB, Mckay CR, Passamani ER, Radford MJ, Riner RN, Schwartz JB, Shaw RE, Shemin RJ, Van Fossen DB, Verrier ED, Watkins MW, Phoubandith DR, Furnelli T. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001 38 2114-2130
18. Nokin J, Vekemans M, L'Hermite M, Robyn C. Circadian periodicity of serum prolactin concentration in man. Br Med J 1972 3 561-562
19. Reuwer AQ, Twickler MT, Hutten BA, Molema FW, Wareham NJ, Dallinga-Thie GM, Bogorad RL, Goffin V, Smink-Bol M, Kastelein JJ, Boekholdt SM, Khaw KT. Prolactin levels and the risk of future coronary artery disease in apparently healthy men and women. Circ Cardiovasc Genet 2009 2 389-395